The Association between Waist-Hip Ratio and Body Fat Composition, and Metabolic Syndrome: A Study at RSUP dr. Kariadi
DOI:
https://doi.org/10.36408/mhjcm.v11i3.1156Keywords:
Waist to hip ratio, body fat composition, metabolic syndromeAbstract
Background: Metabolic syndrome, which is a collection of symptoms which are usually include of hypertension, hyperglycemia, dyslipidemia, and central obesity, has various fatal complications. Fat composition is known to have a close relationship with complications of metabolic syndrome. However, measurement of fat usually requires expensive tools and methods. Meanwhile, anthropometric indicators such as waist-to-hip ratio (WHR) have links with metabolic syndrome and central obesity. This study examines whether there is a significant relationship between WHR and body fat composition in patients with metabolic syndrome.
Objectives: This study examined relationship between WHR and body fat composition as described in fat percentage, fat mass, visceral fat rating, and degree of obesity in patients with metabolic syndrome.
Methods: Cross-sectional observational analytic study was conducted on 51 metabolic syndrome patients at Endocrine Polyclinic, RS dr. Kariadi. Respondents filled out informed consent and questionnaires and measured WHR and body fat composition using Tanita scales. Data analysis was performed by univariate test and bivariate test (Pearson test, Spearman test, or Mann-Whitney test).
Results: There is a weak significant negative correlation between WHR and body fat percentage (p = 0.023; r = -.0.318). There is no correlation between WHR and fat mass (p=0.312). There is a weak positive significant correlation between WHR and visceral fat rating (p=0.001; r=0.441). And there is no correlation between WHR and the degree of obesity (p=0.785).
Conclusion: WHR has a weak significant correlation with body fat percentage and visceral fat rating in NCEP ATP III metabolic syndrome patients.
Downloads
References
1. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep [Internet]. 2018 Feb 26;20(2):12. Available from: http://link.springer.com/10.1007/s11906-018-0812-z
2. Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022 Jan 12;23(2):786.
3. Hess PL, Al-Khalidi HR, Friedman DJ, Mulder H, Kucharska-Newton A, Rosamond WR, et al. The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. 2017 Aug 23;6(8).
4. Chrisna FF, Martini S. Hubungan antara sindroma metabolik dengan kejadian stroke. Jurnal Berkala Epidemiologi. 2016;4(1):25–36.
5. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease. 2017 Aug 22;11(8):215–25.
6. Paredes S, Fonseca L, Ribeiro L, Ramos H, Oliveira JC, Palma I. Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity. Scientific Reports. 2019 Dec 13;9(1):11792.
7. Verma M, Rajput M, Sahoo S, Kaur N, Rohilla R. Correlation between the percentage of body fat and surrogate indices of obesity among adult population in rural block of Haryana. Journal of Family Medicine and Primary Care. 2016;5(1):154.
8. Chang E, Varghese M, Singer K. Gender and Sex Differences in Adipose Tissue. Current Diabetes Reports. 2018 Sep 30;18(9):69.
9. Gadekar T, Dudeja P, Basu I, Vashisht S, Mukherji S. Correlation of visceral body fat with waist–hip ratio, waist circumference and body mass index in healthy adults: A cross sectional study. Medical Journal Armed Forces India. 2020 Jan;76(1):41–6.
10. Frank AP, de Souza Santos R, Palmer BF, Clegg DJ. Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J Lipid Res. 2019 Oct;60(10):1710–9.
11. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015 Feb 15;402:113–9.
12. Arif M, Gaur DK, Gemini N, Iqbal ZA, Alghadir AH. Correlation of Percentage Body Fat, Waist Circumference and Waist-to-Hip Ratio with Abdominal Muscle Strength. Healthcare (Basel). 2022 Dec 7;10(12).
13. Wu Y, Li D, Vermund SH. Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity. Int J Environ Res Public Health. 2024 Jun 10;21(6).
14. Khanna D, Peltzer C, Kahar P, Parmar MS. Body Mass Index (BMI): A Screening Tool Analysis. Cureus. 2022 Feb 11.
15. Ward LC. Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur J Clin Nutr. 2019 Feb 8;73(2):194–9.
16. Dobrowolski P, Prejbisz A, Kuryłowicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome – a new definition and management guidelines. Archives of Medical Science. 2022 Aug 30;18(5):1133–56.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Reza Aditya Afriansyah, Kristophorus Hery Nugroho Hario Seno, Aryu Chandra, Dwi Ngestiningsih (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
